Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABVC Biopharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 291.8% | USD 54.44M | -7.9x | -0.22 | USD 3.35 | -6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nuscale Power | NYSE | Utilities | Electrical Utilities & IPPs | 243.9% | USD 6.70B | -17x | 0.98 | USD 50.25 | 7.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -28.4% Downside | Upgrade to Pro+ | |
Metaplanet | OTC Markets | 230.7% | USD 5.94B | 260.2x | 3.35 | USD 8.99 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
IREN Ltd | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 220.9% | USD 4.34B | -45.5x | 2.05 | USD 17.94 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.8% Upside | Upgrade to Pro+ | |
D Wave Quantum | NYSE | Technology | Software & IT Services | 194.2% | USD 5.97B | -32.1x | 2.96 | USD 18.89 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.7% Downside | Upgrade to Pro+ | |
Robinhood Markets | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 166.5% | USD 96.84B | 60.6x | 0.05 | USD 109.74 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.6% Downside | Upgrade to Pro+ | |
Ast Spacemobile | NASDAQ | Technology | Telecommunications Services | 147.9% | USD 14.39B | -31.6x | 0.5 | USD 57.98 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -21.7% Downside | Upgrade to Pro+ | |
Coinbase Global | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 139.8% | USD 106.92B | 71x | 14.26 | USD 419.78 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -27.9% Downside | Upgrade to Pro+ | |
Ascentage Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 115.8% | USD 3.49B | -30.1x | -1.05 | USD 40.39 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -30.7% Downside | Upgrade to Pro+ | |
Septerna | NASDAQ | Healthcare | Biotechnology & Medical Research | 112.7% | USD 559.21M | -3.2x | 0.06 | USD 12.55 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Futu | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 101.6% | USD 22.36B | 26.8x | 0.46 | USD 160.57 | 7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.1% Downside | Upgrade to Pro+ | |
Argo Corp | OTC Markets | Technology | Software & IT Services | 101.2% | USD 68.72M | -0.07 | USD 0.50 | 8.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
51Talk Online Education DRC | NYSE | Academic & Educational Services | Miscellaneous Educational Service Providers | 99.8% | USD 172.44M | -37x | -0.51 | USD 29.43 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ProQR Therapeutics NV | NASDAQ | Healthcare | Biotechnology & Medical Research | 98.2% | USD 238.08M | -5.9x | 3.94 | USD 2.26 | -5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Phathom Pharma | NASDAQ | Healthcare | Pharmaceuticals | 97.3% | USD 553.70M | -1.5x | 0.1 | USD 7.95 | -4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hims Hers Health | NYSE | Healthcare | Healthcare Providers & Services | 85% | USD 11.28B | 67.5x | 0.01 | USD 50.38 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.7% Downside | Upgrade to Pro+ | |
Critical Metals Corp | NASDAQ | Basic Materials | Metals & Mining | 79.9% | USD 464.14M | -1x | USD 4.48 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Astera Labs | NASDAQ | Technology | Semiconductors & Semiconductor Equipment | 73.2% | USD 16.84B | 359.3x | 3.69 | USD 102.13 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.1% Downside | Upgrade to Pro+ | |
CureVac NV | NASDAQ | Healthcare | Biotechnology & Medical Research | 72.8% | USD 1.21B | 5.8x | 0.03 | USD 5.39 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1% Upside | Upgrade to Pro+ | |
Yuanbao | NASDAQ | 72.1% | USD 1.24B | 6.5x | 0.05 | USD 27.47 | 3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Stoke Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | 71.9% | USD 721.77M | 15.4x | 0.11 | USD 13.22 | 7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kr1 | OTC Markets | Financial | Investment Banking & Investment Services | 63.3% | USD 67.05M | 6.4x | -0.14 | USD 0.55 | 34.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Up Fintech | NASDAQ | Financial | Investment Banking & Investment Services | 59.5% | USD 1.86B | 22.3x | 0.25 | USD 10.58 | 6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.8% Upside | Upgrade to Pro+ | |
Abivax ADR | NASDAQ | Healthcare | Biotechnology & Medical Research | 55.5% | USD 636.09M | -0.27 | USD 9.95 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
NYSE | Technology | Software & IT Services | 54.2% | USD 27.35B | 232x | 2.19 | USD 148.24 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.9% Upside | Upgrade to Pro+ | ||
Blueprint Medicines Corp | NASDAQ | Healthcare | Biotechnology & Medical Research | 52.9% | USD 8.38B | -52.8x | -1.12 | USD 129.46 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.4% Downside | Upgrade to Pro+ | |
Sailfish Royalty | OTC Markets | Basic Materials | Metals & Mining | 52.4% | USD 128.60M | 158.5x | 0.87 | USD 1.74 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DeFi Tech | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 50% | USD 1.09B | 55.8x | 0.38 | USD 3.27 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Himalaya Shipping | NYSE | Industrials | Freight & Logistics Services | 49.3% | USD 315.41M | 20.1x | 0.14 | USD 6.79 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.2% Upside | Upgrade to Pro+ | |
Arrowhead Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 49.1% | USD 2.31B | -15.1x | -0.22 | USD 16.76 | -11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gold Royalty | NYSE | Financial | Investment Banking & Investment Services | 45.4% | USD 404.05M | -122.2x | -1.4 | USD 2.37 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.6% Upside | Upgrade to Pro+ | |
Capital Clean Energy | NASDAQ | Industrials | Freight & Logistics Services | 41.8% | USD 1.41B | 40.6x | 0.95 | USD 23.93 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.3% Upside | Upgrade to Pro+ | |
Elron Electronic Industries | OTC Markets | Financial | Investment Banking & Investment Services | 39.6% | USD 99.94M | 4.4x | 0.01 | USD 1.54 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Volitionrx Ltd | NYSE | Healthcare | Biotechnology & Medical Research | 37.8% | USD 69.54M | -2.5x | -0.07 | USD 0.68 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Regenxbio Inc | NASDAQ | Healthcare | Biotechnology & Medical Research | 37.4% | USD 411.17M | -2.7x | -0.06 | USD 8.16 | -6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NewAmsterdam Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 35.9% | USD 2.49B | -11.9x | -0.41 | USD 22.20 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dominari Holdings | NASDAQ | Financial | Investment Banking & Investment Services | 35.1% | USD 78.93M | -1x | 0.08 | USD 5.39 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avadel Pharma | NASDAQ | Healthcare | Pharmaceuticals | 34.9% | USD 1.05B | -36.6x | -0.47 | USD 10.83 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
China Fund | NYSE | Financial | Collective Investments | 34.8% | USD 155.06M | 8.1x | USD 15.52 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kuros Biosciences | OTC Markets | Healthcare | Biotechnology & Medical Research | 34% | USD 1.37B | -285.9x | -4.26 | USD 35.78 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tetragon | OTC Markets | Financial | Collective Investments | 33.2% | USD 1.40B | 4.2x | USD 17.50 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Mirum Pharmaceuticals | NASDAQ | Healthcare | Pharmaceuticals | 32.8% | USD 2.57B | -32.3x | -0.59 | USD 51.93 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.6% Upside | Upgrade to Pro+ | |
Financial 15 | OTC Markets | Financial | Collective Investments | 32.3% | USD 447.96M | 1.7x | USD 7.16 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
SANUWAVE | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 30.9% | USD 338.48M | -7x | -0.55 | USD 39.24 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Centessa Pharmaceuticals | NASDAQ | Healthcare | Biotechnology & Medical Research | 27.6% | USD 2.10B | -7.3x | 0.33 | USD 15.69 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BeOne Medicines DRC | NASDAQ | Healthcare | Biotechnology & Medical Research | 27.5% | USD 34.95B | -68.1x | -1.74 | USD 294.55 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.8% Upside | Upgrade to Pro+ | |
Ares Commercial RE | NYSE | Real Estate | Residential & Commercial REITs | 26.9% | USD 243.58M | -18.1x | -0.26 | USD 4.43 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.9% Upside | Upgrade to Pro+ | |
Dividend 15 Split | OTC Markets | Financial | Investment Banking & Investment Services | 25.9% | USD 623.44M | 2x | USD 4.66 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Cellectis | NASDAQ | Healthcare | Biotechnology & Medical Research | 25.5% | USD 131.78M | -3x | -0.04 | USD 1.82 | -5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Perella Weinberg Partners | NASDAQ | Financial | Investment Banking & Investment Services | 25.5% | USD 1.23B | -96.4x | -1.13 | USD 19.75 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.5% Upside | Upgrade to Pro+ |